Method of making magnetics assembly
    11.
    发明授权
    Method of making magnetics assembly 有权
    制作磁性装配的方法

    公开(公告)号:US08869383B2

    公开(公告)日:2014-10-28

    申请号:US13523076

    申请日:2012-06-14

    IPC分类号: H01F7/06 H01F17/06 H01F27/28

    摘要: A magnetics assembly (100) including a transformer (1) made of litz wire. The transformer includes a toroid core (2) and a bundle of wires (3) winding around the toroid core. The bundle of wires includes first to eighth wires, and has a central portion with all eight wires twisted together and winding around the toroid core. First and second ends of the bundle of wires oppositely extend out from the toroidal core. The ends of the first to eighth wires are connected to form a primary and a secondary coils of the transformer, wherein the second ends of the first wire and the second wire, and the first ends of the third wire and the fourth wire are sorted out to form central taps (35, 36) of the primary and secondary coils, respectively.

    摘要翻译: 磁性组件(100)包括由绞合线制成的变压器(1)。 变压器包括环形磁芯(2)和缠绕在环形磁芯周围的电线束(3)。 电线束包括第一至第八导线,并且具有中心部分,所有八条线绞合在一起并围绕环形芯线缠绕。 线束的第一和第二端从环形芯相对地延伸出来。 连接第一至第八导线的端部以形成变压器的初级线圈和次级线圈,其中第一线和第二线的第二端以及第三线和第四线的第一端被整理 以分别形成初级和次级线圈的中心抽头(35,36)。

    Process for preparation of timosaponin B II
    12.
    发明授权
    Process for preparation of timosaponin B II 有权
    timosaponin B的制备方法II

    公开(公告)号:US08765925B2

    公开(公告)日:2014-07-01

    申请号:US11579101

    申请日:2005-04-21

    IPC分类号: C07H1/08 C07H19/01 C07J71/00

    CPC分类号: C07J71/00

    摘要: A method for preparation of Timosaponin BII, which uses Chinese traditional medicine Rhizoma Anemarrhenae or fresh rhizoma or fibrous root of Anemarrhena asphodeloides Bge. as raw material, and comprises isolation of Timosaponin BII by one or more processes selected from solvent extraction, resin adsorption, polyamide chromatography, reversed phase column chromatography, Sephadex LH-20 column chromatography, etc, combining with conventional drying method such as reduced pressure drying, freeze drying, spray drying, and so on. Timosaponin BII obtained by the present method is of over 90% purity, and the method is simple, practicable and suitable for industrial production.

    摘要翻译: 一种使用中药根茎或新鲜根茎或Anemarrhena asphodeloides Bge的纤维根的Timosaponin BII的制备方法。 作为原料,通过选自溶剂萃取,树脂吸附,聚酰胺色谱法,反相柱色谱法,Sephadex LH-20柱色谱法等一种或多种方法分离Timosaponin BII,结合常规干燥方法如减压干燥 ,冷冻干燥,喷雾干燥等。 本方法获得的Timosaponin BII纯度超过90%,方法简单,实用,适合工业生产。

    Method and server side and terminal for finding interactive electric service guide
    13.
    发明授权
    Method and server side and terminal for finding interactive electric service guide 有权
    方法和服务器端和终端查找交互式电气服务指南

    公开(公告)号:US08726315B2

    公开(公告)日:2014-05-13

    申请号:US12403843

    申请日:2009-03-13

    摘要: A method and a service side and a terminal for finding an interactive electronic service guide. Said method comprises: the server side down-issuing the information corresponding to the finding interactive ESG service to the terminal through the broadcast channel, and the terminal acquires the information for finding the interactive ESG service in the broadcast channel. Said server side comprises a sending module of the related information for finding interactive ESG service and a down-issue module for the ESG supplier list. The terminal comprises a receiving module of the related information for finding the interactive ESG service and a receiving module for the ESG supplier list.

    摘要翻译: 一种用于查找交互式电子服务指南的方法和服务端以及终端。 所述方法包括:服务器端通过广播信道向终端发送与发现的交互式ESG业务相对应的信息,并且终端获取用于在广播信道中查找交互式ESG业务的信息。 所述服务器侧包括用于发现交互式ESG服务的相关信息的发送模块和用于ESG供应商列表的下发模块。 终端包括用于查找交互式ESG服务的相关信息的接收模块和用于ESG供应商列表的接收模块。

    Immunoassay
    14.
    发明授权
    Immunoassay 失效
    免疫测定

    公开(公告)号:US08679772B2

    公开(公告)日:2014-03-25

    申请号:US12996609

    申请日:2008-06-06

    IPC分类号: G01N33/53

    CPC分类号: G01N33/5438 G01N33/54306

    摘要: The invention provides a highly sensitive immunoassay for detection of a biological species. The immunoassay comprises exposing an electrode to an analyte liquid putatively containing the biological species so as to couple the biological species, if present in the analyte liquid, to a binding antibody on the electrode. The electrode comprises a binding antibody and an anchor group, each being coupled to an electrically conductive substrate, said binding antibody being capable of binding to the biological species and said anchor group being capable of binding to a redox polymer. The electrode is then exposed to an antibody-enzyme liquid comprising an antibody-enzyme species, said antibody-enzyme species comprising a detection antibody capable of binding to the biological species, said detection antibody being coupled to a redox enzyme, whereby, if the analyte liquid comprises the biological species, the redox enzyme couples to the electrode by means of the coupling of both the detection antibody and the binding antibody to the biological species. The electrode is then exposed to a polymer solution comprising the redox polymer and to an enzyme substrate, whereby if the redox enzyme is coupled to the anchor group on the electrode the redox polymer is reduced and couples to the anchor group on the electrode. A voltage is then applied between the electrode and a reference electrode and the electrode is exposed to an oxidizable species, whereby a magnitude of an electric current between said electrode and a reference electrode is indicative of the presence or absence of the biological species.

    摘要翻译: 本发明提供用于检测生物物种的高度灵敏的免疫测定。 免疫测定包括将电极暴露于假设含有生物物质的分析物液体,以将生物物质(如果存在于分析物液体中)与电极上的结合抗体相连接。 电极包含结合抗体和锚定基团,每个锚定基团与导电底物偶联,所述结合抗体能够结合生物物种,所述锚定基团能够结合至氧化还原聚合物。 然后将电极暴露于包含抗体 - 酶物质的抗体 - 酶液体,所述抗体 - 酶物质包含能够结合生物物种的检测抗体,所述检测抗体与氧化还原酶偶联,由此,如果分析物 液体包括生物物种,氧化还原酶通过检测抗体和结合抗体与生物物种的偶联而与电极偶联。 然后将电极暴露于包含氧化还原聚合物和酶底物的聚合物溶液,由此如果氧化还原酶与电极上的锚定基团偶联,则氧化还原聚合物被还原并连接到电极上的锚定基团上。 然后将电压施加在电极和参考电极之间,并且电极暴露于可氧化物质,由此所述电极和参比电极之间的电流的大小指示生物物种的存在或不存在。

    Compositions and methods for bone formation and remodeling
    15.
    发明授权
    Compositions and methods for bone formation and remodeling 有权
    用于骨形成和重塑的组合物和方法

    公开(公告)号:US08637506B2

    公开(公告)日:2014-01-28

    申请号:US10849067

    申请日:2004-05-19

    IPC分类号: A61K31/535 C07C50/18

    摘要: The mechanism by which the high bone mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates the canonical Wnt signaling was investigated. The mutation was previously shown to reduce Dkk protein-1-mediated antagonism, suggesting that the first YWTD repeat domain where G171 is located may be responsible for Dkk protein-mediated antagonism. However, we found that the third YWTD repeat, but not the first repeat domain, is required for DKK1-mediated antagonism. Instead, we found that the G171V mutation disrupted the interaction of LRP5 with Mesd, a chaperon protein for LRP5/6 that is required for the coreceptors' transport to cell surfaces, resulting in less LRP5 molecules on the cell surface. Although the reduction in the level of cell surface LRP5 molecules led to a reduction in Wnt signaling in a paracrine paradigm, the mutation did not appear to affect the activity of coexpressed Wnt in an autocrine paradigm. Together with the observation that osteoblast cells produce autocrine canonical Wnt, Wnt7b, and that osteocytes produce paracrine Dkk1, we believe that the G171V mutation may cause an increase in Wnt activity in osteoblasts by reducing the number of targets for paracrine Dkk1 to antagonize without affecting the activity of autocrine Wnt.

    摘要翻译: 研究了Wnt共同受体LRP5的高骨量(HBM)突变(G171V)调节规范Wnt信号传导的机制。 以前显示突变可以降低Dkk蛋白-1介导的拮抗作用,这表明G171位于第一个YWTD重复结构域可能是Dkk蛋白介导的拮抗作用的原因。 然而,我们发现第三个YWTD重复,但不是第一个重复结构域,是DKK1介导的拮抗作用所必需的。 相反,我们发现G171V突变破坏了LRP5与Mesd的相互作用,Mesd是共受体转运到细胞表面所需的LRP5 / 6的伴侣蛋白,导致细胞表面上较少的LRP5分子。 尽管细胞表面LRP5分子水平的降低导致旁分泌范例中Wnt信号传导的降低,但突变似乎不影响共表达Wnt在自分泌范式中的活性。 连同观察到成骨细胞产生自分泌的正常Wnt,Wnt7b,并且该骨细胞产生旁分泌的Dkk1,我们认为G171V突变可能通过减少旁分泌Dkk1靶向拮抗的目标数量引起成骨细胞中Wnt活性的增加,而不会影响 自分泌Wnt的活性。

    TRIAMCINOLONE ACETONIDE FORMULATIONS FOR TREATING DERMATITIS AND PSORIASIS
    17.
    发明申请
    TRIAMCINOLONE ACETONIDE FORMULATIONS FOR TREATING DERMATITIS AND PSORIASIS 审中-公开
    用于治疗牙龈萎缩症的三氰菊酯乙酰胆碱配方

    公开(公告)号:US20130338127A1

    公开(公告)日:2013-12-19

    申请号:US13695669

    申请日:2011-05-04

    IPC分类号: A61K31/58

    摘要: The present invention is drawn to formulations and related methods for treating dermatitis or psoriasis. The formulation can include triamcinolone acetonide, a polymer selected from the group of a poly(2-hydroxyalkylacrylate), a poly(2-hydroxyalkylmethacrylate), and combinations thereof. The formulation also includes a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent.

    摘要翻译: 本发明涉及用于治疗皮炎或牛皮癣的制剂和相关方法。 制剂可以包括曲安奈德,选自聚(2-羟烷基丙烯酸酯),聚(2-羟烷基甲基丙烯酸酯)和其组合的聚合物。 该制剂还包括包含至少一种挥发性溶剂的挥发性溶剂体系和包含至少一种非挥发性溶剂的非挥发性溶剂体系。

    Catalysts for polymerization of isoprene and preparations and uses thereof
    18.
    发明授权
    Catalysts for polymerization of isoprene and preparations and uses thereof 有权
    用于异戊二烯聚合的催化剂及其制备方法及用途

    公开(公告)号:US08604143B2

    公开(公告)日:2013-12-10

    申请号:US13284744

    申请日:2011-10-28

    摘要: Disclosed are catalyst compositions for isoprene polymerization formed from components comprising (A) at least one titanium halide; (B) at least one organic aluminum compound comprising at least one alkyl aluminum of formula AlR3, wherein each of the three Rs is independently chosen from linear and branched C1-6 alkyl groups; and (C) at least one electron donor comprising at least one polyether compound of formula (I) and/or at least one tetrahydro-furfuryl ether compound of formula (II). Also disclosed are processes for preparation of the catalyst compositions and processes using the catalyst compositions for isoprene polymerization.

    摘要翻译: 公开了由组分(A)至少一种卤化钛组成的异戊二烯聚合催化剂组合物, (B)至少一种包含至少一种式AlR 3的烷基铝的有机铝化合物,其中三个R 3中的每一个独立地选自直链和支链C 1-6烷基; 和(C)包含至少一种式(I)的聚醚化合物和/或至少一种式(II)的四氢糠基醚化合物的至少一种电子给体。 还公开了制备催化剂组合物的方法和使用该催化剂组合物用于异戊二烯聚合的方法。

    METHOD AND SYSTEM FOR WAKING UP REMOTE DEVICES
    19.
    发明申请
    METHOD AND SYSTEM FOR WAKING UP REMOTE DEVICES 有权
    用于调出远程设备的方法和系统

    公开(公告)号:US20130219204A1

    公开(公告)日:2013-08-22

    申请号:US13882410

    申请日:2011-09-08

    IPC分类号: G06F1/32

    摘要: Disclosed are a method and a system for remote wake-up and status check, with a wake-up signal generating unit generating and transmitting a wake-up signal to wake up an electricity supply unit of a remote device to operate normally and provide electricity for the remote device. The wake-up signal has an assigned electric voltage with specific characteristics for detection by the electricity supply unit while in power-off mode and, upon signal detection, the electricity supply unit wakes up to provide normal electric voltage output. The wake-up signal generating unit determines, according to an electric current on a wake-up signal feed line, whether the remote device is in an active mode. A low wake-up energy consumption enables system wake-up and a true powered-off sleep mode.

    摘要翻译: 公开了一种用于远程唤醒和状态检查的方法和系统,其中唤醒信号产生单元产生并发送唤醒信号以唤醒远程设备的电力供应单元以正常运行并为 远程设备。 唤醒信号具有分配电压,具有特定的特性,用于在断电模式下由电力供应单元进行检测,并且在信号检测时,供电单元唤醒以提供正常的电压输出。 唤醒信号发生单元根据唤醒信号馈送线上的电流来确定远程设备是否处于活动模式。 低唤醒能耗使系统唤醒和真正关闭睡眠模式。

    DRUG RELEASING MEDICAL CATHETERS, TUBES, AND DEVICES
    20.
    发明申请
    DRUG RELEASING MEDICAL CATHETERS, TUBES, AND DEVICES 有权
    药物释放医用导管,管和设备

    公开(公告)号:US20130197455A1

    公开(公告)日:2013-08-01

    申请号:US13638577

    申请日:2011-03-30

    申请人: Jie Zhang

    发明人: Jie Zhang

    IPC分类号: A61L29/16 A61M25/00

    摘要: The present disclosure relates to medical catheters, tubes, and other medical devices, systems, and methods. The catheter, tube, or other medical device is capable of releasing drugs for extended periods of time. Drugs can be loaded into the wall thereof with a loading solution. The drug in the wall of the device and in the loading solution can be in dynamic equilibrium, yielding stable and easy-to-manufacture products.

    摘要翻译: 本公开涉及医疗导管,管和其它医疗装置,系统和方法。 导管,管或其他医疗装置能够长时间释放药物。 药物可以用加载溶液装入其壁。 装置壁和装载液中的药物可以处于动态平衡状态,产生稳定且易于制造的产品。